Establishing secure connection…Loading editor…Preparing document…

Clinical Research Services Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

CLINICAL RESEARCH SERVICES AGREEMENT

This Clinical Research Services Agreement (the Agreement) is entered into as of by and between:

Sponsor Name:

Service Provider Name:

WHEREAS

WHEREAS, Sponsor is conducting a clinical investigation described as and seeks qualified services in connection with the conduct of that investigation; and

WHEREAS, Service Provider represents that it has the expertise, staff, facilities and regulatory knowledge to provide the clinical research services described in this Agreement; and

NOW, THEREFORE, in consideration of the mutual promises contained herein the parties agree as follows:

1. SCOPE OF WORK

Service Provider shall perform the Services in accordance with the study protocol, applicable law, Good Clinical Practice, and any written instructions agreed by the parties. Any change to the Scope of Work that materially affects cost or schedule must be approved in writing by Sponsor and Service Provider and shall be documented as a written amendment to this Agreement.

2. PAYMENT TERMS

Invoices shall be submitted by Service Provider in accordance with the Payment Schedule and shall include sufficient detail of services rendered. Sponsor shall pay invoiced amounts within days of receipt, unless undisputed in good faith. Late payments shall accrue interest at the rate of per month (or the maximum lawful rate if lower).

All amounts payable under this Agreement are exclusive of taxes. Sponsor shall be responsible for taxes imposed on payments to Service Provider, except for taxes based on Service Provider's net income.

3. TERM AND TERMINATION

The term of this Agreement shall commence on and shall continue until unless earlier terminated in accordance with this Section.

Either party may terminate this Agreement for convenience upon days' prior written notice. Either party may terminate for material breach if such breach is not cured within thirty (30) days after written notice specifying the breach. Termination shall not relieve Sponsor of obligations to pay for Services performed and reasonable wind-down costs incurred through the effective date of termination.

4. CONFIDENTIALITY

For purposes of this Agreement, "Confidential Information" means any non-public information disclosed by one party to the other that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information. Confidential Information includes study data, patient-level information, protocols, regulatory submissions and financial terms of this Agreement.

Each receiving party shall: (a) hold Confidential Information in strict confidence using at least the same degree of care it uses to protect its own confidential information but no less than reasonable care; (b) use Confidential Information solely to perform its obligations or exercise its rights under this Agreement; and (c) not disclose Confidential Information to any third party except to those employees, contractors and investigators who have a need to know and who are bound by obligations of confidentiality no less restrictive than those in this Agreement.

The obligations in this Section shall not apply to information that: (i) is or becomes generally available to the public other than by breach of this Agreement; (ii) was known to the receiving party without restriction prior to disclosure; (iii) is rightfully received from a third party without restriction; or (iv) is independently developed by the receiving party without use of the disclosing party's Confidential Information. A receiving party may disclose Confidential Information to the extent required by law or regulation, provided that, to the extent legally permitted, it provides prompt written notice to the disclosing party to allow for a protective order or other appropriate remedy.

5. INDEMNIFICATION & INSURANCE

Each party (the Indemnifying Party) shall indemnify, defend and hold harmless the other party (the Indemnified Party) from and against third-party claims arising out of the Indemnifying Party's gross negligence, willful misconduct, or breach of this Agreement. The Indemnifying Party's indemnity obligations are subject to the Indemnified Party giving prompt notice of the claim, providing reasonable information and assistance, and permitting the Indemnifying Party to control the defense and settlement, provided that no settlement admitting fault by the Indemnified Party may be entered without its consent.

Service Provider shall maintain general liability and professional liability insurance in commercially reasonable amounts and shall provide evidence of such insurance upon reasonable request.

6. GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to its conflict of laws principles. The parties submit to the exclusive jurisdiction of the state and federal courts located within that State for any dispute arising out of this Agreement.

7. ENTIRE AGREEMENT

This Agreement, including any attachments and written amendments signed by both parties, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, proposals and representations, whether written or oral. No amendment, modification or waiver of any provision of this Agreement shall be effective unless in writing and signed by authorized representatives of both parties.

8. MISCELLANEOUS

Neither party shall assign this Agreement without the prior written consent of the other, except that Sponsor may assign to an affiliate or successor in interest. If any provision is held invalid or unenforceable, the remainder of this Agreement shall remain in full force and effect. Headings are for convenience only and do not affect interpretation.

Sponsor (Print Name):

By:

Date:

Service Provider (Print Name):

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Clinical Research Services Agreement Is and when it applies

A Clinical Research Services Agreement is a written contract between a study sponsor and a service provider (often a contract research organization, investigative site, or vendor) that defines the scope, responsibilities, deliverables, timelines, payment structure, and compliance obligations for clinical study activities. Typical topics include study conduct, monitoring, data collection and transfer, regulatory reporting, investigational product handling, publication rights, confidentiality, intellectual property allocation, indemnities, insurance, audit rights, and termination. Properly executed, the agreement supports regulatory compliance and operational clarity across the study lifecycle.

Why the Clinical Research Services Agreement matters for studies

A clear Clinical Research Services Agreement allocates risk, sets measurable deliverables, and documents regulatory responsibilities. It helps prevent disputes, aligns expectations for payments and milestones, preserves data integrity, and records audit and inspection rights that regulators and sponsors expect during FDA or HHS oversight.

Why the Clinical Research Services Agreement matters for studies

Which teams and organizations typically prepare or sign this agreement

Legal, compliance, clinical operations, finance, and quality assurance stakeholders commonly collaborate on negotiation, execution, and post‑execution monitoring.

  • Pharmaceutical sponsors and biotech companies — Legal, clinical operations, and contracts teams that oversee study funding and vendor selection.
  • Contract research organizations (CROs) and service providers — Operational teams responsible for executing trial activities and meeting milestones.
  • Investigative sites and principal investigators — Site leadership and research coordinators that enroll participants and deliver study data.

Key signatories and their roles

Sponsor Legal Counsel

Reviews liability, indemnity, IP allocation, and compliance terms. Ensures the contract matches sponsor policies, funding schedules, and regulatory obligations and confirms authority to bind the sponsor prior to signature.

Principal Investigator

Accepts operational responsibilities at the site level, verifies capabilities to perform study procedures, ensures informed consent processes, and confirms adherence to protocol, Good Clinical Practice, and applicable regulations.

Core clauses to include in a Clinical Research Services Agreement

Include clauses that establish scope, obligations, and protections so parties can operate and respond to regulatory or operational issues during a study.

Scope of Work

Define study activities, deliverables, timelines, milestones, and acceptance criteria in measurable terms so responsibilities and performance triggers are unambiguous and auditable.

Payment and Milestones

Specify payment amounts, invoicing cadence, milestone conditions, reimbursement of study costs, and any holdbacks or conditions for final payment to avoid later disputes.

Data Handling and IP

Describe data ownership, permitted uses, de‑identification standards, transfer mechanisms, and intellectual property assignments applicable to study results and inventions.

Compliance and Reporting

Require adherence to Good Clinical Practice, applicable FDA requirements, adverse event reporting, recordkeeping obligations, and cooperation with regulatory inspections.

Confidentiality and Publication

Protect confidential information, define publication review procedures, and set timelines for sponsor review of manuscripts and public disclosures.

Indemnity and Insurance

Allocate risk through indemnification language and minimum insurance limits for professional liability, clinical trials liability, and other study‑specific coverages.

Stepwise process to prepare and execute the agreement

Follow this sequence to draft, review, sign, and archive a Clinical Research Services Agreement efficiently.

  • 01
    Draft SOW: Create a detailed statement of work and attach study exhibits.
  • 02
    Assign Reviewers: Route to legal, clinical operations, finance, and compliance for parallel review.
  • 03
    Signatures: Confirm authorized signatories and capture signatures with dates.
  • 04
    Distribution: Send executed copies to all parties and to study master file.

How contracts typically move from draft to archive

A standardized workflow reduces delays and helps preserve auditability during regulatory inspections.

  • Upload Document: Place the finalized agreement and exhibits into the repository.
  • Place Fields: Add signature, initials, and date fields where required.
  • Authenticate Signers: Use appropriate signer authentication based on sensitivity.
  • Archive: Store executed documents and audit trails in a secure archive.

Typical digital workflow settings for clinical contracts

Configure these settings to match study risk and regulatory requirements when completing agreements electronically.

Field Configuration
Signature Order Sequential or parallel per sponsor preference
Authentication Email + SMS code or knowledge‑based authentication
Conditional Fields Show payment fields only after milestone selection
Retention Setting Automatic retention tag for study master file

Technical and platform considerations for electronic execution

Confirm the vendor offers audit trails, encryption at rest and in transit, and, if handling PHI, a Business Associate Agreement.

  • Supported Formats: PDF and Word DOCX accepted
  • Integrations: Salesforce, NetSuite, Google Workspace, Box
  • Authentication Options: Email, SMS, KBA, or enterprise SSO

Security and compliance checklist for executed agreements

Encryption: TLS 1.2/1.3 in transit; AES‑256 at rest
Audit Trail: Timestamps, IP, and action log retained
HIPAA: BAA required for PHI handling
21 CFR Part 11: Controls for FDA‑regulated records available
SOC 2: Type II report available on request
ESIGN / UETA: Legal acceptance of electronic signatures

Key risks and regulatory consequences to avoid

Noncompliance Fines: Regulatory penalties and enforcement action
Data Breach Costs: Notification, remediation, and liability exposure
Study Delays: Missed milestones can suspend enrollment
Contract Termination: Loss of funding or service interruption
Reputational Harm: Sponsor and site credibility affected
Indemnity Exposure: Significant financial obligations under indemnities

Common preparation mistakes to avoid

  • Leaving scope vague or referencing outdated exhibits causes disputes and scope creep during execution.
  • Failing to attach the statement of work or budget leads to payment delays and differing expectations.
  • Using unauthorized signatories or missing signature authority verification can invalidate obligations or delay the start of work.
  • Omitting data privacy language or a BAA when PHI is involved increases regulatory and breach risk for both parties.

Key timing and deadline considerations

Track these timepoints to maintain study momentum and meet regulatory and contractual obligations.

Negotiation Window:

Allow 2–8 weeks depending on complexity and internal approvals

Execution Deadline:

Set a firm date for signature to trigger study start activities

Site Initiation:

Typically scheduled after executed contract and regulatory approvals

Interim Reports:

Define frequency for safety and monitoring reports

Record Retention Start:

Begins on effective date or study closeout, whichever applies

Sequential milestones from contract draft to study closeout

Use a milestone checklist to coordinate contracting, site activation, and study closeout with clear handoffs.

01

Proposal and SOW Finalized

Agree detailed study activities and budget before drafting contract

02

Contract Negotiation

Resolve liability, indemnity, and data clauses with legal teams

03

Execution and Site Initiation

Obtain signatures, complete regulatory filings, and initiate site training

04

Closeout and Archival

Finalize deliverables, reconcile payments, and archive records

Comparison of representative eSignature vendors and starting prices

Signatory platforms differ by price model, authentication options, and regulatory features. The table below summarizes core pricing and compliance items.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no card required Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes (Business Premium) Available on select plans Available on select plans Available on select plans Available on select plans
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes (BAA required) Yes (BAA available) Yes (BAA available) No No
Envelope Cap No envelope cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Practical examples of eSignature and contracting in action

Real customer experiences illustrate common benefits and operational changes when digitizing clinical contract execution.

Optica Ventures (COO)

The interface is simple and easy to use for our team and customers.

  • Streamlined signature capture reduced cycle time.
  • Optica centralized templates and routing, enabling faster turnaround while preserving audit logs and regulatory traceability across multiple sponsor engagements.

Fertility Centers of Illinois (Founder)

The API and responsiveness supported our integration needs.

  • Improved document control.
  • The center automated consent and agreement flows, achieving consistent recordkeeping and easier responses to audits while reducing manual follow up by administrative staff.

Frequently asked questions about completing and signing this agreement

Answers to common questions about electronic execution, notarization, signatures, retention, and amendments for Clinical Research Services Agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.